Home
/
BIOAGE LABS, INC. (BIOA)
BIOAGE LABS, INC. (BIOA) Technical Analysis
Updated: 2026-05-01 03:19 UTC · Last close: 16.85 (-0.06%) · Support: 13.93 · Resistance: 17.92
BIOAGE LABS, INC. (BIOA) technical analysis page covering price structure, support and resistance, momentum conditions and a fundamentals snapshot from WOI Scanner.
⚠️ Risk Line
losing 13.93 would weaken the current structure.
Quick Read
The next meaningful technical decision is likely to occur between support at 13.93 and resistance at 17.92.
🎯 Decision Map
The next meaningful technical decision is likely to occur between support at 13.93 and resistance at 17.92. Clearing resistance would strengthen the constructive case, while a failure through support would damage the present setup. Pattern-based invalidation is near 22.66; losing that area would weaken the active formation considerably.
📊 Technical Summary
The latest close for BIOAGE LABS, INC. (BIOA) came in at 16.85 (-0.06%). The chart is sitting below its 50-day average while still holding above the 200-day average, suggesting shorter-term weakness inside a still positive long-term backdrop. 20-day momentum is running at -4.96%; price remains inside its roughly 52-week range (3.76–22.92); and ATR14 volatility is elevated at roughly 7.42% of price. RSI(14) stands around 44.4, which keeps the momentum picture broadly balanced. RSI has been drifting lower recently, suggesting that upside momentum may be cooling slightly. MACD is positioned under the signal line, suggesting momentum recovery has not fully developed yet. The MACD histogram is negative and weakening further, which reflects continued downside pressure. The chart is currently flagging Double top. Near-term structure is defined by support at 13.93 and resistance at 17.92. A clean break above resistance would strengthen the chart, while a loss of support would put the current setup under pressure. Fundamentals snapshot: Revenue: 2.05M · Net income: -20.17M · EPS (basic): -0.56. The interactive chart adds overlays, pattern context and a fuller structure view for deeper review.
💼 Fundamentals Snapshot
Source: sec
Company
BIOAGE LABS, INC.
Note: This is an algorithmic technical snapshot (not financial advice).